Page results
-
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
How UCLH uses clinical data in research.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
Information for patients from overseas visiting UCLH hospitals.
File results
-
FOI/2024/0297 - Policy for parasitic infestation assessment and treatment of patients
-
FOI/2024/0301 - Nursing associates and trainee nursing associates policy
-
FOI/2024/0302 - Mental health diagnosis for patients aged 11 to 25
-
FOI/2024/0303 - Lost histology (histopathology) specimens/ sample tracking systems
-
FOI/2024/0308 - Misuse of Electronic Patient Record systems (EPRS)
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease